David Zuckerman is president of Customized Improvement Strategies and is the author of "Pharmaceutical Metrics."
Big Pharma is finally making a commitment to partner-based outsourcing.
While execution quality doesn't deal with the protocol from a scientific standpoint, it is nonetheless critical to a successful outcome.
Supply Chain Strategy: Managing risk and opportunity in a changing global landscape
Sponsored By PricewaterhouseCoopers LLP Optimizing the Multi-Sponsor REMS Experience (Risk Evaluation & Mitigation Strategies)
Sponsored By PricewaterhouseCoopers LLP Effective Resource Planning: Reducing Clinical Project Risk and Operating Cost
Sponsored By ClearTrial